Blood Flow Restriction for Multiple Sclerosis

University of Central Florida, Orlando, FL
Multiple Sclerosis+2 More ConditionsBlood Flow Restriction - Other
Eligibility
18 - 55
Female
What conditions do you have?
Select

Study Summary

This trial will compare the benefits of two different types of strength training for people with Multiple Sclerosis.

Eligible Conditions
  • Multiple Sclerosis
  • Clinical Trial
  • Blood Flow Restriction

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Study Objectives

5 Primary · 1 Secondary · Reporting Duration: Day 3, Week 4 and 8, Day 29

Week 4
Change in Functional Outcomes- 10meter
Change in Functional Outcomes- 30CST
Change in Functional Outcomes- 6min walk
Change in Functional Outcomes- CST
Change in Functional Outcomes- MFIS
Week 4
Changes in Strength

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

2 Treatment Groups

Standard of Care
1 of 2
Blood Flow Restriction
1 of 2

Active Control

Experimental Treatment

30 Total Participants · 2 Treatment Groups

Primary Treatment: Blood Flow Restriction · No Placebo Group · N/A

Blood Flow Restriction
Other
Experimental Group · 1 Intervention: Blood Flow Restriction · Intervention Types: Other
Standard of Care
Other
ActiveComparator Group · 1 Intervention: Standard of Care · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: day 3, week 4 and 8, day 29

Who is running the clinical trial?

University of Central FloridaLead Sponsor
54 Previous Clinical Trials
31,401 Total Patients Enrolled
AdventHealthOTHER
100 Previous Clinical Trials
21,502 Total Patients Enrolled

Eligibility Criteria

Age 18 - 55 · Female Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Who else is applying?

What state do they live in?
Florida100.0%
How old are they?
18 - 65100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%

Frequently Asked Questions

Are there still opportunities available to participate in this research project?

"That is correct. The information available on clinicaltrials.gov reveals that this trial is currently seeking participants. This study was first posted on January 1st, 2022 and was last updated on December 15th, 2021. They are looking for 30 individuals from 1 location." - Anonymous Online Contributor

Unverified Answer

Is this research project limited to a certain age demographic?

"The age limit for participants in this study is 55 years old. All participants must also be older than 18 years old." - Anonymous Online Contributor

Unverified Answer

Would I be able to join this research project if I qualify?

"Eligible participants for this study must be between 18-55 years old, have a current diagnosis of multiple sclerosis, a female sex, an Expanded Disability Status Score of 6.5 or lower, the ability to walk unassisted for 10 meters, and the commitment to attend all 29 testing sessions over the 14 weeks that the trial will take place." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.